{"id":144570,"date":"2025-02-18T09:51:47","date_gmt":"2025-02-18T08:51:47","guid":{"rendered":"https:\/\/www.startupbusiness.it\/exolab-italia-completes-e5m-series-a-round\/144570\/"},"modified":"2025-02-18T11:53:22","modified_gmt":"2025-02-18T10:53:22","slug":"exolab-italia-completes-e5m-series-a-round","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/","title":{"rendered":"ExoLab Italia completes \u20ac5m Series A round"},"content":{"rendered":"\n<p><strong>ExoLab Italia, a biotech start-up specialising in the realisation of exosome-based products and applications, announces that it has completed a EUR 5 million<\/strong> capital increase in a Series A financing round. <\/p>\n\n<p>The operation involves four investment funds: <strong>Dsm-firmenich Ventures, CDP Venture Capital with an equal placement of Fondo Acceleratori and Fondo Italia Venture II, Fondo Linfa, managed by Riello Investimenti, and Maia Ventures.<\/strong><\/p>\n\n<p>The start-up was founded in 2020 with the aim of developing cosmetic, <strong>pharmaceutical and nutraceutical applications for plant exosomes, cellular vesicles derived from fruit that can enhance the efficacy of traditionally used ingredients<\/strong>. The idea is to exploit the abundant resources of Italian organic agriculture and turn them into the ground for scientific discoveries. Thanks to a proprietary technology and an advanced research and development programme, ExoLab Italia is now committed to the innovation of natural functional actives. &#8220;The funds raised will make it possible to realise an ambitious strategic plan, which includes industrial scale-up, internationalisation, and a decisive investment in human and territorial capital,&#8221; says Gabriele Campi, CEO of ExoLab (pictured here with the other co-founders), in a note.    <\/p>\n\n<p><strong>&#8216;We are particularly proud of this partnership with ExoLab,&#8217; comments Alessandro Scortecci, chief direct investment officer of CDP Venture Capital. &#8216;Plant-derived exosomes are emerging as a revolutionary frontier in biomedical technologies and sciences and, thanks to the advanced research conducted by the ExoLab team, they stand out as a potential game changer in the cosmetic, nutraceutical and pharmaceutical sectors.<\/strong> Their extraordinary bioactive properties, coupled with their high biocompatibility, make them ideal for developing innovative applications to improve health and wellbeing, opening up new horizons for evolving markets.<\/p>\n\n<p>ExoLab Italia was founded by <strong>Mariantonia Logozzi (chief technology officer) and Stefano Fais (scientific director), with experience at the Department of Oncology and Molecular Medicine of the Istituto Superiore di Sanit\u00e0 (ISS), together with Lorenzo Cilli (chief financial officer) and Valerio Carconi (head of marketing &amp; sales)<\/strong>. The innovative vision behind the project immediately attracted the interest of <strong>Scientifica Venture Capital, ExoLab Italia&#8217;s historic investor<\/strong>, which recognised the company&#8217;s potential and supported its growth from the outset. Within Scientifica&#8217;s laboratories in L&#8217;Aquila, ExoLab Italia set up its innovative research and development programme. Today, Scientifica continues to support ExoLab as a strategic partner, working alongside the company in this new phase.   <\/p>\n\n<p>Thanks to the support of the new investors, ExoLab Italia will move from a 300 square metre research and production laboratory to a major facility of over a thousand square metres, also in L&#8217;Aquila, designed to optimise production processes: this is one of the levers to become the world&#8217;s leading player in the production of plant-based exosome ingredients. The expansion will not only increase production capacity, but will also offer new opportunities for implementing advanced research projects.  <strong>&#8216;This capital increase represents a turning point for ExoLab Italia. We are laying the foundation for a future of sustainable growth and continuous innovation,&#8217; says Logozzi. <\/strong><\/p>\n\n<p>With the investment, ExoLab Italia aims to consolidate its presence in European and non-European markets and to enter new key geographic areas. This step will be made possible by a strategy aimed at building local partnerships and strengthening the brand&#8217;s visibility on a global level. Internationalisation goes hand in hand with an overall increase in staff: the company plans to hire 20 new resources over the next three years, with a focus on the recruitment of specialised talents and highly qualified figures.  <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotech start-up innovating in exosome-based applications receives capital from several investment funds<\/p>\n","protected":false},"author":125,"featured_media":144568,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1317],"tags":[1350,1143,1137,1136],"companies":[2491],"journalist":[1518],"class_list":["post-144570","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-news","tag-biotech-en","tag-investments","tag-italy-en","tag-startup-en-2","companies-exolab-italia-en","journalist-editorial-staff-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/i-fondatori-di-Exolab.webp","width":150,"height":100,"crop":false,"srcset":false,"alt":"biotech startup"},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/i-fondatori-di-Exolab.webp","width":800,"height":533,"crop":false,"srcset":false,"alt":"biotech startup"},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/i-fondatori-di-Exolab.webp","width":800,"height":533,"crop":false,"srcset":false,"alt":"biotech startup"}},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ExoLab Italia completes \u20ac5m Series A round<\/title>\n<meta name=\"description\" content=\"Biotech start-up innovating in exosome-based applications receives capital from several investment funds\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ExoLab Italia completes \u20ac5m Series A round\" \/>\n<meta property=\"og:description\" content=\"Biotech start-up innovating in exosome-based applications receives capital from several investment funds\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-18T08:51:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-18T10:53:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/i-fondatori-di-Exolab.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"ExoLab Italia completes \u20ac5m Series A round\",\"datePublished\":\"2025-02-18T08:51:47+00:00\",\"dateModified\":\"2025-02-18T10:53:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/\"},\"wordCount\":575,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/i-fondatori-di-Exolab.webp\",\"keywords\":[\"biotech\",\"investments\",\"italy\",\"startup\"],\"articleSection\":[\"Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/\",\"name\":\"ExoLab Italia completes \u20ac5m Series A round\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/i-fondatori-di-Exolab.webp\",\"datePublished\":\"2025-02-18T08:51:47+00:00\",\"dateModified\":\"2025-02-18T10:53:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"Biotech start-up innovating in exosome-based applications receives capital from several investment funds\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/exolab-italia-completes-e5m-series-a-round\\\/144570\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/i-fondatori-di-Exolab.webp\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/i-fondatori-di-Exolab.webp\",\"width\":800,\"height\":533,\"caption\":\"biotech startup\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ExoLab Italia completes \u20ac5m Series A round","description":"Biotech start-up innovating in exosome-based applications receives capital from several investment funds","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/","og_locale":"en_US","og_type":"article","og_title":"ExoLab Italia completes \u20ac5m Series A round","og_description":"Biotech start-up innovating in exosome-based applications receives capital from several investment funds","og_url":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/","og_site_name":"Startupbusiness.it","article_published_time":"2025-02-18T08:51:47+00:00","article_modified_time":"2025-02-18T10:53:22+00:00","og_image":[{"width":800,"height":533,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/i-fondatori-di-Exolab.webp","type":"image\/webp"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"ExoLab Italia completes \u20ac5m Series A round","datePublished":"2025-02-18T08:51:47+00:00","dateModified":"2025-02-18T10:53:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/"},"wordCount":575,"commentCount":0,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/i-fondatori-di-Exolab.webp","keywords":["biotech","investments","italy","startup"],"articleSection":["Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/","url":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/","name":"ExoLab Italia completes \u20ac5m Series A round","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/i-fondatori-di-Exolab.webp","datePublished":"2025-02-18T08:51:47+00:00","dateModified":"2025-02-18T10:53:22+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"Biotech start-up innovating in exosome-based applications receives capital from several investment funds","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/exolab-italia-completes-e5m-series-a-round\/144570\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/i-fondatori-di-Exolab.webp","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/i-fondatori-di-Exolab.webp","width":800,"height":533,"caption":"biotech startup"},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":["Funding News"],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=144570"}],"version-history":[{"count":1,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144570\/revisions"}],"predecessor-version":[{"id":144571,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144570\/revisions\/144571"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/144568"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=144570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=144570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=144570"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=144570"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=144570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}